Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date Sort descending
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date Sort descending
    Pfizer and American Academy of Dermatology (AAD): Patient Access to Care
    Release Date:
    Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk Patients
    Release Date:
    Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic Arthritis
    Release Date:
    Pediatric Immunization Series Completion
    Release Date:
    Facilitation of the Diagnosis of Rheumatoid Arthritis
    Release Date:
    Pfizer and NCCN: Metastatic Breast Cancer
    Release Date:
    Improving Care of Chronic Pain- Physician Groups and Health Systems
    Release Date:
    Achievement of Treat-to-Target in Rheumatoid Arthritis
    Release Date:
    Anticoagulation Education - NVAF or VTE
    Release Date:
    Review Process:
    Transition of Care in VTE
    Release Date:
    Chronic Pain Empowerment Platform
    Release Date:
    Disparities in Adult Pneumococcal Vaccination
    Release Date: